Tuesday, July 28, 2015

FDA issues warning for weight-loss pill

The Food and Drug Administration issued a warning to consumers who use the weight loss supplement Slim-30 Herb after an agency lab analysis found it contained substances could endanger some patients with histories of heart disease, heart failure, arrhythmias, or stroke.

FDA issues warning for weight-loss pill

0 comments

The Food and Drug Administration issued a warning to consumers who use the weight loss supplement Slim-30 Herb after an agency lab analysis found it contained substances could endanger some patients with histories of heart disease, heart failure, arrhythmias, or stroke.

Marketed as a natural supplement, the FDA lab analysis found the pills contained N-Desmythy sibutramine and traces of sibutramine, a medication sold as Meridia by the drug maker Abbott Laboratories. The drug is know to “substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke,” the FDA stated.

The agency said it has not received any reports of injuries associated with the Slim-30 Herb Supplement. Still, the FDA cautioned consumers to stop taking the supplement and return it for a full refund.

Click here to see the FDA alert on Slim-30 Herb Supplement.

To check out more Check Up items go to www.philly.com/checkup.

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog

Check Up covers regional health news and a wide array of healthcare topics from pharmaceutical happenings to patient safety. Read about some of our bloggers here.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Hooman Noorchashm, M.D., Ph.D. Cardiothoracic surgeon in the Philadelphia area
Amy J. Reed, M.D., Ph.D. Anesthesiologist and Surgical Intensivist in the Philadelphia Area
Latest Health Videos
Also on Philly.com:
letter icon Newsletter